Framingham-Based Xenetic Biosciences To Expand Oncology Pipeline; Announces Agreement With CLS Therapeutics
editor In full transparency, the following is a press release submitted to SOURCE media through its business wire service. *** FRAMINGHAM – Xenetic Biosciences, Inc., a biopharmaceutical company focused on advancing…